Lenzilumab
Catalogue number:
HY-P99207-5mg
Supplier:
Size:
5 mg
Product is available in:
Applications:
Cancer-programmed cell death
Target:
SARS-CoV
Alternative Names:
KB 003
- Data sheet: View or download
- MSDS: View or download
- Protocol: View or download
Product Description:
Lenzilumab (KB 003) is a human monoclonal antibody targeting CSF2/GM-CSF for COVID-19, chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML) studies[1][2].